T2 Bio & Health Tech
by main topic: 134
Issues 15
- IssueAgenda 3: Accelerating green and white bio-industry innovation through synthetic biology2 trends · 0 signals
- IssueAquatic Breakthroughs1 trends · 0 signals
- IssueClothes that Care1 trends · 0 signals
- IssueContinuous behavioural sensing joined to genomics1 trends · 0 signals
- IssueDesigner Cells1 trends · 0 signals
- IssueFully autonomous laboratories draw capital but remain outside mainstream practice1 trends · 1 signals
- IssueGenetic tools becoming routine across sectors via food acceptance1 trends · 0 signals
- IssueHome bioengineering enabled by machine learning and kits1 trends · 0 signals
- IssueLife sciences: from conglomerate to orchestrated Bioweave1 trends · 0 signals
- IssueOrgan Printing1 trends · 0 signals
- IssueRadical longevity innovation and the pursuit of healthspan0 trends · 0 signals
- IssueRegulating AI-bio innovation and securing health data, with Korea's AI bio strategy1 trends · 0 signals
- IssueSocial acceptability of biotechnology0 trends · 0 signals
- IssueTestosterone moves from medical treatment to lifestyle optimization without a boundary1 trends · 0 signals
- IssueViral Solution1 trends · 0 signals
Trends 31
Macroeconomy & Finance 1
Industry & Supply Chains 11
- TrendAgeing and chronic disease sustain steady demand growth for Korean biohealth0 signals
- TrendAnimal-alternative testing platforms: organoids, organ chips and medical twins1 signals
- TrendCRISPR making biology programmable across agriculture, health and industry4 signals
- TrendClimate regulation drives demand for biorefinery conversion and new green-bio niches0 signals
- TrendEngineering biology takes off as AI enters biomanufacturing and gene editing advances2 signals
- TrendNon-hallucinogenic neuroplastogens shift the field from the trip to the underlying biology2 signals
- TrendPharma: payers demand real-world value while regulators tighten scrutiny of AI and data integrity2 signals
- TrendSleep diagnosis migrates from clinical labs to home testing and telemedicine3 signals
- TrendSustainable biomanufacturing from agricultural waste0 signals
- TrendTrend 7: pharmaceutical R&D shifts from manual experimentation to AI-guided discovery3 signals
- TrendUniversal vaccine platforms for rapid response to emerging infectious diseases1 signals
Labor & Future of Work 3
- TrendGenetic risk assessment is being paired with behavioral health coaching2 signals
- TrendNeurotechnology and affect sensing move from clinic to consumer device8 signals
- TrendThe human-machine hybrid13 signals
Climate Change & Adaptation 1
Resources, Food & Water 1
Geopolitics & Security 1
- TrendWider access to engineering biology raising misuse risk3 signals
Tech·Digital Policy 1
Demographics & Migration 2
Welfare & Health 9
- TrendA single treatment opens a wider pathway of behaviour, support, and spending2 signals
- TrendAI drives a bio revolution from genetic analysis to personalised medicine2 signals
- TrendBCI-based neural circuit modulation for precision mental health care1 signals
- TrendEngineered cells for drug development and personalised cancer therapy0 signals
- TrendGenomic and biometric data used for personalised care and authentication0 signals
- TrendHyper-personalised precision medicine and health management platforms1 signals
- TrendTechnology 6: the body's own vesicles are engineered as drug carriers3 signals
- TrendTechnology 7: a vaccine synthesized around one patient's tumour mutations4 signals
- TrendTrend 6: healthcare becomes the proving ground for voice AI3 signals
AI & Computing 1
Signals 88
Macroeconomy & Finance 6
- SignalAbout nine in 10 clinical drug candidates fail, which the chapter partly attributes to computing error
- SignalAn estimated $79.4 billion of public investment built the mRNA infrastructure now reused
- SignalBrazil's GLP-1 patents expired in March 2026 and price is the stated barrier for 35% of interested consumers
- SignalGene-editing cargo crossed the blood-brain barrier in 2025 and a $1.5 billion pact followed
- SignalProjections put 25 million Americans on GLP-1 treatment by 2030
- SignalVoice AI platforms hit record deal activity in 2025 with most rated as deploying or scaling
Industry & Supply Chains 9
- SignalA trillion-dollar drugmaker builds a discovery supercomputer with a chip vendor
- SignalAI agents in early drug discovery raised wet lab capacity 21 to 30 percent at one company
- SignalAI expected to cut vaccine development from ten years to under one and create a 10 to 30 trillion won market by 2030
- SignalBrainwave readings used to close a car sale
- SignalGLP-1-linked muscle loss spawns products such as weighted vests designed for women
- SignalGlobal biotechnology market valued at 1.55 trillion dollars in 2023
- SignalHuman augmentation market projected at $1.39 trillion by 2034
- SignalNeurotechnology market nearing 20 billion dollars in 2026, growing 14 percent a year
- SignalNovo Nordisk partners with Anthropic to test 'Claude Science' in drug R&D workflows
Labor & Future of Work 3
Resources, Food & Water 4
- SignalCRISPR Boosts Potato Resistance to Late Blight Disease / Plant viruses open new routes for gene editing
- SignalHuman genome sequencing fell from a decade to a single day
- SignalKAUST develops precise large-fragment gene insertion method for crops, published in Nature Biotechnology
- SignalOne in six US households tried GLP-1s by July 2024 and cut grocery spend about 6%
Democracy & Governance 2
Tech·Digital Policy 6
- SignalConsumer DNA firm sold over 12 million kits and filed for bankruptcy in 2025
- SignalGLP-1 penetration in Europe is estimated at about 2% of the population
- SignalOver 200 exosome clinical trials since 2022, with yields reported up to fifty-fold higher
- SignalSecond child death disclosed in China gene-editing trial within months
- SignalSeven psychedelic candidates have reached FDA Phase 3 trials
- SignalSpain's CRISPR position: origin of the molecular basis, EU advocacy and the 2025 ONAC report
Demographics & Migration 1
Welfare & Health 37
0-3 years 30
- Signal75% of Gen Z and 73% of millennials use health-tracking tools against 32% of boomers
- Signal80% use a health app or wearable, rising above 90% in the UAE and Saudi Arabia
- SignalA global pharma company simulates enrollment and diversity targets on a clinical-trial digital twin
- SignalAI diagnostics lift sensitivity from 72% to 80%; drug discovery success from 10% to 70%
- SignalAmylyx reports positive Phase 3 LUCIDITY topline results for avexitide in post-bariatric hypoglycemia
- SignalAn autonomous surgical robot completes gallbladder surgery at reported 100% accuracy
- SignalCARDIO-TTRansform phase III trial of eplontersen misses primary endpoint at ESC Congress 2026
- SignalCRISPR Clinical Trials 2026: In Vivo Delivery as the Single Most Important Transition
- SignalCRISPR moves from rare blood disorders towards common cardiovascular risk
- SignalCedars-Sinai Phase 3 trial shows deramiocel cell therapy preserves cardiac function in Duchenne muscular dystrophy
- SignalCutlery that produces saltiness electrically
- SignalDietary advice from gut flora, blood work and glucose response
- SignalDiets derived from a customer's genetic profile
- SignalFDA Approves First Broad RAS-Targeted Drug for Metastatic Pancreatic Cancer
- SignalFDA Clears First Dual Glucose-Ketone Continuous Monitoring Wearable
- SignalFDA accepts EIT Pharma's NDA for lonafarnib to treat chronic hepatitis D
- SignalFDA grants accelerated approval to Replimune's Tudriqev for advanced melanoma
- SignalFDA grants breakthrough therapy designation to Lilly's olomorasib for pancreatic cancer
- SignalFDA grants priority review to Belite Bio's tinlarebant for Stargardt disease
- SignalFDA grants volixibat breakthrough therapy and orphan designations for PSC
- SignalGLP-1 users track fibre, protein, and calories more and plan to spend more on health
- SignalLongevity investment up 220% to $8.5 billion with animal lifespans extended 30-74%
- SignalMD Anderson phase 1 trial reported disease stabilization in pancreatic cancer
- SignalMSK trial reports 90% survival among immune responders in pancreatic cancer
- SignalNo geroprotector yet proven both safe and effective in humans
- SignalPatients increasingly ask doctors for a named GLP-1 brand
- SignalPersonalized vaccine plus pembrolizumab cut recurrence or death risk by 49% in melanoma
- SignalUK Biobank holds data on half a million participants
- SignalWearable EDA and heart-rate-variability sensors are credited with up to 84% stress detection accuracy
- SignalWorld-first trial finds statins safely cut heart attack and stroke risk in over-70s
4-10 years 5
- SignalAntimalarial compound hailed as 'exciting step forward' in fight against disease
- SignalBlood biomarkers can forecast the onset of ALS symptoms
- SignalExpanded Access Case Report of SNIPR001 CRISPR Phage Therapy Published
- SignalNeuralink Expands Human Trials to 21 Participants — VOICE Trial Targets 140 Words/min
- SignalPsilocybin Helps Most Veterans With PTSD, Small Study Shows
AI & Computing 11
- SignalBROADMIND non-surgical brain-computer interface EEG kit (Kickstarter)
- SignalBrain-computer interface market projected to quadruple by 2034
- SignalConsumer earbuds patented as biosignal sensors
- SignalDual- versus Single-Suggestion AI Support for Radiographic Interpretation in Residents: Randomized Multireader Study
- SignalEyewear that reads the wearer's facial muscles continuously
- SignalImplanted interfaces enter broader clinical trials
- SignalMIT Technology Review — 10 Breakthrough Technologies 2026: AI Drug Discovery, Backward Molecule Design
- SignalProgramming protein shape as an explicit design layer via CAD blueprint-guided diffusion
- SignalQuantum biosensing and imaging expected to reach high-end medical device level around 2030
- SignalResearch suggests AI can cut drug development time by up to 40 percent
- SignalStudy Finds Most Explainable-AI Methods for ECG Diagnosis Miss Clinically Relevant Signal Regions
Space & Mobility 1
Values & Lifestyles 3
Other 5
- Signal'Almost Alive': Scientists built artificial cell-like blob 'SpudCell' that eats, grows, and divides
- SignalFDA New Guidance Enables Multi-Mutation Gene Editing Trials; CRISPR Pipeline Expands
- SignalField Medical reports 12-month Field PULSE trial results with 94.2% pulmonary vein isolation durability
- SignalGenome sequencing cost fell from 300 million dollars to 525 dollars
- SignalPreprint identifies TRIM28 as a stabiliser of ovarian cell identity
Objects with this as a secondary topic 128
Macroeconomy & Finance 3
Industry & Supply Chains 13
- Signal82% name a nutrition purchase intent; 63% diagnostics, 60% coaching, 55% devices
- SignalAnalysts put Spravato global sales at $2 billion in 2025
- SignalBCI neuromodulation market projected to reach tens of billions of dollars by the early 2030s
- IssueFinally Graphene1 trends · 0 signals
- TrendHome and distributed 3D printing decentralising manufacturing1 signals
- SignalHome sleep apnea testing market projected to reach $966 million by 2035
- SignalInterest reaches 63% for health insights and diagnostics, 60% coaching, 54% devices
- TrendMaterials Revolution5 signals
- SignalMore than 400 billion dollars of pharma commitments to US facilities create a new AI testbed
- SignalPerfect Day, Nestle and EVERY have moved fermentation-derived proteins onto retail shelves
- TrendProducts are wrapped in data, diagnostics, coaching, monitoring, and subscriptions5 signals
- SignalTestosterone, hair transplant and steroid markets scale up around male appearance anxiety
- IssueThe gap between health goals and health behaviour is read as commercial headroom1 trends · 1 signals
Labor & Future of Work 3
Climate Change & Adaptation 2
Resources, Food & Water 10
- SignalAlternative protein production expected to reach TRL 8 to 9 with unit costs falling 70 to 90 percent
- SignalAnimal-free egg white from a Finnish start-up
- SignalBrazil approved a transgenic eucalyptus growing 20 percent faster in 2015
- IssueCarbon for Water1 trends · 0 signals
- TrendClimate-responsive food production technologies building hybrid food systems1 signals
- IssueCrop diversification and genetically engineered varieties for resilience1 trends · 0 signals
- TrendDiet is being individualised by biology and widened by unfamiliar raw materials7 signals
- SignalEditorial: Crop suitability and food security: the evolution of new technologies
- SignalGLP-1 adoption pushes demand towards smaller portions and higher-protein formats
- TrendTechnology 5: microbes given transferred genes produce target molecules in fermentation tanks2 signals
Ecosystems & Biodiversity 2
- IssueEcological risks of gene-edited trees: gene flow, biodiversity loss and water use1 trends · 0 signals
- IssueGenetic material in water and soil as continuous biodiversity monitoring1 trends · 0 signals
Geopolitics & Security 2
- IssueBiological data arms races and state data hacks1 trends · 0 signals
- TrendMalicious actors combining AI and engineering biology for bioweapons0 signals
Tech·Digital Policy 25
0-3 years 13
- IssueCRISPR hurdles: therapy cost and evaluation, restrictive EU rules, biosafety and benefit sharing1 trends · 0 signals
- IssueConflicting interests in dual-use technologies need society-wide debate3 trends · 0 signals
- SignalDSIT guidance on screening synthetic nucleic acids
- SignalEight psychedelic candidates hold FDA breakthrough therapy designation
- SignalFDA Modernization Act 3.0 and national strategies accelerate acceptance of non-animal test methods
- SignalFDA removes the testosterone cardiovascular black box warning in February 2025
- IssueGoverning neurodata: protection, anti-manipulation and cognitive identity before capabilities outrun rules1 trends · 1 signals
- SignalNeurodata law: Chile's constitution, Colorado and California, the EU AI Act and Cantabria's 2025 draft
- TrendPsychedelic developers converge on FDA approval as the main route to scale3 signals
- SignalThe US Inflation Reduction Act and health technology assessment regimes are named as pricing pressure
- SignalUK commission proposes 44 recommendations to overhaul AI healthcare regulation
- SignalUNESCO adopts the first global ethical standard for neurotechnology
- SignalUS states begin legislating on neural data ownership
4-10 years 9
- TrendConsumer neurotechnology spreading beyond clinics and generating neurodata2 signals
- IssueEthics, social acceptance and lagging licensing rules as bottlenecks for life-science technologies4 trends · 0 signals
- SignalFDA's Roadmap to Reducing Animal Testing — New Approach Methodologies in drug development
- IssueGenetic privacy, liability and access inequality in quantum-enabled precision medicine1 trends · 1 signals
- IssueMedical-act definitions, data ownership and interoperability gaps for hyper-personalised health platforms1 trends · 0 signals
- IssueMental privacy and voluntariness in enhancement adoption1 trends · 0 signals
- IssueRegulatory gaps and long-term safety uncertainty for anti-ageing therapies1 trends · 0 signals
- IssueSlow guideline development, patient tissue rules and missing organoid libraries constrain animal-alternative testing1 trends · 1 signals
- IssueUnsettled regulation, safety evidence and data privacy for brain stimulation and BCI therapies1 trends · 0 signals
11-30 years 1
- TrendTrend F: Harmonising technology with human values1 signals
Other 2
- IssueNo approved therapy, unsettled dosing units and an unresolved manufacturing bottleneck1 trends · 1 signals
- IssueSimulation cannot count as regulatory evidence because shared validation standards do not exist1 trends · 1 signals
Demographics & Migration 2
- IssueAgenda 8: Realising Vital Ageing and leading the global silver industry through Age Tech2 trends · 2 signals
- IssueRealigning Korea's R&D and innovation policy toward demographic change1 trends · 1 signals
Cities & Housing 2
Welfare & Health 36
0-3 years 13
- SignalA $200 million public-private partnership was announced in March 2026 to fund further trials
- SignalCMS repeals fast-track payment pathway for breakthrough medical devices
- SignalClaim that nearly half of cancer cases trace to modifiable factors
- IssueDemand outruns the care pathway, pushing patients into channels of their own2 trends · 1 signals
- SignalGalleri Blood Test Fails to Reduce Late-Stage Cancers in Major NHS Trial
- TrendHealth shifts from episodic and institution-led to continuous and consumer-led6 signals
- SignalObstructive sleep apnea estimated to affect one billion people, mostly undiagnosed
- TrendPandemic and biorisk concern receding1 signals
- SignalPwC's Global Health Report names prevention, prediction, decentralisation, and outcomes
- SignalSleep is a top goal for 40% but only 32% track it, and just 56% rate their sleep well
- IssueTrust and safety, not capability, is named as the binding constraint on voice AI in care1 trends · 1 signals
- SignalUnattended home sleep tests among Medicare beneficiaries grew 632.6 percent in a decade
- IssueVulnerable persons and biological data at the end of risk cascades2 trends · 0 signals
4-10 years 18
- SignalA projected 100,000 worker shortage in the US by 2028 is used to justify voice agents
- TrendAI-based population health risk prediction and intervention platforms0 signals
- TrendAdvanced Health and Nutrition3 signals
- TrendAntimicrobial resistance as a rapidly growing global threat8 signals
- SignalCareMirror: Bringing Caregiver Wellbeing into the Dementia Care Ecosystem
- IssueDiet as scalable mental and brain health intervention1 trends · 0 signals
- IssueEmerging fungal health and food security risks, including multidrug-resistant strains1 trends · 1 signals
- SignalEvaluating Ambient Clinical Scribes in India: The Need for Multilingual Real-World Clinical Conversation Data
- SignalExpert outlook: healthy life expectancy up ten years or more and AI monitoring covering 70 percent of elder care
- IssueGeneric wellness gives way to life-stage and physiology-specific demand1 trends · 1 signals
- TrendGrowing antimicrobial and antifungal resistance1 signals
- TrendHealth paradigm shift from treatment toward prediction, prevention and continuous management1 signals
- IssuePer-patient cost above $100,000 could confine the therapy to well-resourced health systems1 trends · 0 signals
- TrendProviders move from reactive care to proactive, decentralised, personalised models5 signals
- IssueSecurity for medical devices as they approach end of life1 trends · 0 signals
- SignalStudy finds consumer wearable heart-rate data tracks state-level economic hardship in the US
- TrendTrend 2: health broadens into many measurable dimensions and outruns consumers' sense of progress8 signals
- IssuemRNA delivery limits, cold-chain inequity and uncertain regulation for universal vaccine platforms1 trends · 0 signals
11-30 years 2
- TrendAntimicrobial resistance eroding antibiotic effectiveness2 signals
- TrendTrend M: Threats to sustainable health systems5 signals
Other 3
- IssueGenome sequencing at birth integrated with NHS records1 trends · 0 signals
- IssueMultidrug-resistant microbes making routine surgery dangerous1 trends · 0 signals
- IssueThe Power of Radio1 trends · 0 signals
AI & Computing 20
0-3 years 6
- SignalG-CARL: Grounded Checklist-Aligned Reward Learning for Patient-Oriented Medical Report Interpretation
- SignalGenerating Benchmark Health Data Using a Tabular Diffusion Transformer
- SignalIBM and Moderna ran the largest quantum protein folding simulation to date in 2025
- SignalQuantifying the relationship between clinical safety and environmental impact in therapeutic LLMs
- TrendThe first health move becomes digital, with AI and wearables answering before care does3 signals
- SignalTrust Is Not a Score: Runtime Assurance Contracts for High-Risk AI Agents
4-10 years 8
- TrendA flywheel of AI, data, infrastructure and investment is automating scientific research5 signals
- TrendAI turns sleep tracking into predictive health monitoring2 signals
- TrendConvergence of key technologies accelerated by AI2 signals
- SignalIBM quantum protein simulation / Microsoft & Quantinuum quantum error correction in Nature (800x logical qubits)
- TrendPhysical AI medical and care robots interacting with patients in the real world1 signals
- SignalReconstructing what a person is looking at from brain scans
- SignalReport's list of emerging applications, some still at research level
- SignalStanford reports an AI model predicting disease risk from sleep study data
11-30 years 4
- SignalFirst Biological Qubit Created from Living Cell Protein — UChicago PME Breakthrough
- SignalNew Pipeline Targets EHR Feature-Engineering Bottleneck for Heart Failure Research
- SignalPreprint examines how research values shape foundation model development
- SignalProtein found in living cells turned into functioning qubit — UChicago PME
Other 2
- IssueFresh Threads1 trends · 0 signals
- TrendTechnology 8: molecular behaviour modelled directly instead of approximated4 signals
Energy & Climate Tech 1
Digital Infrastructure & Cyber 3
- SignalAsan Medical Center trained AI on 300,000 records across three hospitals without moving raw data
- IssueData Helix1 trends · 0 signals
- TrendTechnological Vulnerabilities3 signals
Values & Lifestyles 4
- SignalConsumers bought in three or four wellbeing categories in a year; 69% keep two or more habits
- IssuePlant-based diets and cultivated meat reducing disease burden1 trends · 0 signals
- TrendTrend E: Changes in life and space0 signals
- IssueTrust is a precondition, not a soft variable, because the arrangements have no precedent3 trends · 1 signals